ClinicalTrials.govpublic full text
Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy
neuroendocrine tumor grade 3, neuroendocrine carcinoma, pancreatic carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 812056
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.